Delivery Order SPE2DB24D2106-SPE2DB25FAVLR
Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $19K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $20,733.91 by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Otezla 30 mg tablets (60-count packages). The delivery order, which carries no set-aside designation, is scheduled for completion by August 5, 2025, with performance to occur in Conshohocken, Pennsylvania. This award is issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,210.71 by the Defense Logistics Agency (DLA) on September 12, 2025. The delivery order, which expires on September 15, 2025, is for the supply of Otezla 30 mg tablets (60-count units) to be delivered to Conshohocken, Pennsylvania. This award was issued without a set-aside designation, demonstrating the vendor's competitive...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Otezla 30 mg tablets (60 count) valued at $8,067.46 under a firm fixed-price contract type. The award was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and does not utilize a set-aside designation. DMS Pharmaceutical Group, based in Park Ridge, Illinois, will perform this delivery order from its Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,438.54 to DMS Pharmaceutical Group Inc. for the supply of Otezla 30 mg tablets (60-count packages). The contract, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler...
- The U.S. Defense Logistics Agency (DLA) awarded a $25,679.07 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the supply of 60-count bottles of Otezla 30 mg tablets, a pharmaceutical product used to treat certain medical conditions. This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract SPE2DB24D2106 with DLA, which has a ceiling value of up to $4,999,999 and enables...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $29,581.75, is for the delivery of OTEZLA 30 MG TABLET 60S to support the medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. has a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $5,241.08, is for the delivery of Otezla 30 mg tablets. It is not associated with a set-aside designation. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $29,849.49 firm fixed-price delivery order is for Otezla 30 mg tablets, a prescription medication, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on September 27, 2024. The $8,422.01 order is for the pharmaceutical product Otezla 30 mg tablet, 60 count, and is part of the larger SPE2DB indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA. The SPE2DB IDC allows the DLA to issue firm fixed-price delivery...
- This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract has a ceiling value of $4,092.62 and covers the delivery of the pharmaceutical product "OTEZLA 30 MG TABLET 60S" with a period of performance through May 6, 2024. The DLA SPE2DB program is a single-award indefinite delivery contract (IDC) valued at up to...